Adrulipase Alfa Likely Global Name for CF Non-porcine PERT Candidate

Adrulipase Alfa Likely Global Name for CF Non-porcine PERT Candidate

303661

Adrulipase Alfa Likely Global Name for CF Non-porcine PERT Candidate

The World Health Organization (WHO) proposed a compound name to better identify MS1819, an investigational therapy for exocrine pancreatic insufficiency in people with cystic fibrosis (CF), with scientists globally. MS1819 may soon be called “adrulipase alfa.” The WHO is expected to make a final decision on the candidate’s International Nonproprietary Name (INN) by November. “Assignment of an INN signifies that a pharmaceutical substance has reached a point in its development where it is now beneficial to…

You must be logged in to read/download the full post.